Penn Medicine opened a $376 million facility in September of 2025 in Philadelphia to drive pioneering research in autoimmune disorders. Positioned atop an existing 250,000-sf office tower, the eight-story overbuild features wet laboratories, a vivarium, and a BSL-3 lab for the processing of infectious disease specimens.
The University of California, San Francisco began construction in August of 2025 on the Life Sciences Building located in the Dogpatch Power Station redevelopment. Designed by Herzog & de Mueron and Stantec, the transformative facility will drive bioscience innovation by bringing together research, best-in-class patient care, and graduate-level training with venues for new biomedical companies.
Brown University is constructing the William A. and Ami Kuan Danoff Laboratories in Providence’s Jewelry District to support integrated life sciences research. The 300,000-sf facility was designed by TenBerke and Ballinger to catalyze innovation and the commercialization of impactful scientific and medical breakthroughs. The seven-story building will provide six levels of wet and dry laboratories and research cores for programs in biology, medicine, neuroscience, bioengineering, and public health.
Southern Research opened a $98 million biotechnology center in August of 2025 in Birmingham, Alabama. Designed by HOK and Williams Blackstock Architects, the 150,000-sf building will advance research crucial to human health and address pressing biomedical threats. The five-level structure features BSL-3 laboratories spanning 7,500 sf that provide essential biocontainment capacity for the study of infectious diseases.
Masaryk University (MU) is constructing the MUNI BioPharma Hub to drive excellence in research, education, and innovation in Brno in the Czech Republic. Offering three underground levels and six stories above grade, the 163,504-sf project was designed by Pelčák a partner architekti to combine leading-edge scientific infrastructure with modern academic venues.
Designing and building labs in the unlikely and constrained location of the prestigious Pacific Design Center (PDC) with Hollywood as a backdrop is a daunting task, requiring adherence to quality expectations, facilities management guidelines in a non-research environment, separation from existing high-end tenants, and compliance with infrastructure requirements. Cedars-Sinai, one of the largest nonprofit medical centers in the U.S., accepted the challenge after deciding to expand its research portfolio. Growing beyond its limited campus is necessary to accommodate the rapid growth of its research facilities and to aid in recruiting top scientists by providing innovative facilities with optimum resources. Hospital officials looked a half mile from their campus to the PDC, a designated cultural resource building complex designed by Cesar Pelli in the 1970s. Known in the 1980s and 1990s as a vibrant hub of premier art, design, and architectural showrooms, many of the tenants now have online shops rather than physical space in the cluster of buildings, leaving vacancies available for lease and an opportunity for Cedars-Sinai’s growth.
GenesisM, a joint venture between Bain Capital and Botanic Properties, broke ground on a Class A biomanufacturing facility in July of 2025 in Bedford, Mass. Designed by Perkins&Will, the sophisticated development addresses a critical need for purpose-built life sciences infrastructure in the Greater Boston region.
The University of California, Berkeley is planning to begin construction in spring of 2026 on a seven-story facility for the Innovative Genomics Institute and Bakar Labs. Designed by DGA and Weiss/Manfredi, the development will expand research capabilities in genomics engineering with CRISPR technologies and provide critical infrastructure for life science companies scaling their operations.
Beacon Capital Partners and Trammell Crow Company completed Hyde Park Labs in July of 2025 in Chicago. The $225 million project was designed by Elkus Manfredi Architects, Moody Nolan, and Interactive Design Architects to offer 300,000 rsf of Class A lab and office space spread over nine floors. With 4,200 sf of chemical storage space and vivarium access, the 13-story facility includes an executive boardroom, four floors of above- and below-ground parking, and street-level retail.
The University of Sydney celebrated the beginning of construction on the AU$780 million Sydney Biomedical Accelerator in May of 2025. Created in partnership with the Government of New South Wales and Sydney Local Health District, the 387,500-sf structure will forge a vital link between the Royal Prince Alfred Hospital and the university's Camperdown campus.
Construction will begin in fall of 2025 on the first phase of a 1,614,600-sf expansion of the Wellcome Genome Campus in the Hinxton, Cambridgeshire. The transformative project is led by master developer Urban&Civic and will extend the site from 125 to 440 acres. Supported by infrastructure works including roads, bridges, and utility networks, this visionary initiative will also deliver 1,500 homes, a recreation center, a swimming pool, and other amenities.
Ivanhoé Cambridge and Lendlease celebrated the completion of a $545 million life sciences center in Boston in June of 2025. Designed by SGA, FORUM strategically integrates Class A laboratory environments with collaborative workspaces and engaging community amenities. The 350,000-rsf facility offers flexible floor plates spanning 50,000 sf, supported by robust infrastructure to meet the demands of next-generation research programs.
The University of Kansas Cancer Center broke ground in May of 2025 on a visionary complex that will collocate groundbreaking biomedical research with world-class patient care in Kansas City. Designed by HDR and Hoefer Welker, the $450 million facility will deliver a comprehensive array of services in a single integrated location, as well as providing direct access to leading-edge clinical trials.
Sanofi opened its new U.S. headquarters in May of 2025 at M Station West in Morristown, New Jersey. Developed by SJP Properties and Scotto Properties, the seven-story, 260,000-sf facility was designed by Gensler to collocate approximately 2,000 employees with leadership roles in business operations, finance, R&D, human resources, technology, general medicines, specialty care, vaccines, and manufacturing and supply.
Gilead Sciences is constructing the Cancer Research Center in Foster City to accelerate the creation of novel solutions for pressing medical challenges. Driven by the company's enterprise master plan, the project is part of a strategic initiative to develop an internal research infrastructure that advances discovery in key focus areas and brings new technological capabilities in-house. The 182,000-sf facility was designed by Gensler to catalyze synergies between 54 clinical programs spanning oncology, inflammation, and virology.
